Content Usage Guidelines

Every word we publish at LuciDerma is created to help people care for their skin—face, body, and everything in between. Our work is protected by copyright. Yet we believe good information should travel. Responsibly. Accurately. With credit. That’s why we offer limited syndication under the conditions below.

Web Republication (Excerpts)

Want to quote us? Please do. Just keep it faithful to the original and follow these rules:

  1. Limit: You may republish up to 200 words or the first two paragraphs, whichever is shorter.
  2. Credit: Clearly credit LuciDerma as the original source. Example: “Source: LuciDerma.”
  3. Link: Include a dofollow hyperlink to the original LuciDerma article. Readers should be able to find the full piece with one click.
  4. Canonical: When possible, set the canonical tag to the original LuciDerma URL.
  5. Integrity: Do not edit wording in a way that alters medical meaning, safety guidance, ingredient concentrations, or outcomes.
  6. Attribution clarity: Quotes must be visually attributed to LuciDerma (byline or inline note). No framing that implies your team authored our work.
  7. Media assets: Our images, graphics, logos, and videos are not included in excerpt permissions. Separate written permission is required.

Full Article Licensing

Need to republish a full article—for print, education, internal training, or a corporate newsletter? We license content. One-time reprints. Ongoing syndication. Even custom editorial packages tailored to your audience. Our skin care content is produced by experienced editors and fact-checked against reputable dermatology sources to keep guidance accurate, practical, and safe.

Tell us what you need, and we’ll help you do it right—clean rights, clean metadata, and clear timelines.

Intellectual Property Inquiries

Questions about permissions, translations, or academic use? Reach our licensing team via the contact us page. We review requests promptly and aim to protect two things at once: your project’s integrity and our readers’ trust.